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ronal marker, NeuN. Consistent with the immunohistochem-
ical findings, Western blot analysis showed GPER expression 
is only elevated in the ischemic hemisphere of male mice. 
Moreover, GPER mRNA expression in males was elevated at 
4 h but had returned to baseline by 24 h. In conclusion, these 
findings indicate that GPER may be a potential therapeutic 
target after stroke, especially in males, in whom estrogen 
therapy is not feasible.  Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Traditionally, estrogen was considered to mediate its 
actions solely via activation of the classical nuclear recep-
tors, estrogen receptors   and   . However, studies have 
now identified a novel estrogen receptor called G protein-
coupled estrogen receptor (GPER, previously named 
GPR30)  [1, 2] . This former orphan receptor belongs to the 
family of seven transmembrane G protein-coupled recep-
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 Abstract 
 The novel estrogen receptor, G protein-coupled estrogen re-
ceptor (GPER, previously named GPR30), is widely distribut-
ed throughout the male and female brain and, thus, could 
potentially play a role in estrogen-mediated neuroprotec-
tive effects in diseases such as stroke. We hypothesized that 
GPER distribution and expression in the brain of male, intact 
female, and ovariectomized (OVX) mice is increased after 0.5 
h middle cerebral artery occlusion. Using immunohisto-
chemistry, we found that ischemia reperfusion increased 
GPER distribution in the peri-infarct brain regions of male 
mice, but surprisingly not in intact females or OVX mice. Sim-
ilar differences were observed in the male and female hu-
man brain after stroke. In contrast, GPER distribution was de-
creased in the infarct core of all mice examined. Further-
more, GPER immunofluorescence was co-localized with the 
endothelial cell marker, von Willebrand factor, and the neu-
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tors and binds to estradiol (E2) with high affinity and 
potency, thus leading to the unique classification of GPER 
as a membrane-localized estrogen receptor  [3] . GPER ex-
pression has since been identified in tissues of several 
physiological systems, including the nervous, immune, 
cardiovascular and reproductive systems, and it is postu-
lated to also play varied roles in cell growth and cancer, 
and metabolism and obesity  [4] .
 Several studies have demonstrated that GPER is widely 
distributed throughout the central nervous system  [5–8] . 
More specifically, high GPER expression has been identi-
fied in numerous regions of the brain, including the stria-
tum, hippocampus, anterior and posterior pituitary, and 
granule cells of the dentate gyrus  [6, 9] , which is a profile 
distinct from that of the traditional estrogen receptors  [5, 
7] . In addition, we have reported that GPER expression is 
localized throughout the cerebral arterial wall in male and 
female rats  [10] . Due to its high expression and extensive 
distribution in the brain and cerebral vasculature, GPER 
has been proposed as a possible therapeutic target for neu-
rological diseases, including stroke. To date, only two stud-
ies have assessed the role of GPER signaling following 
stroke. A preliminary study of GPER signaling by Zhang 
et al.  [11] demonstrated that chronic pretreatment of ovari-
ectomized (OVX) mice with the GPER agonist, G-1, re-
duces infarct volume at 96 h after stroke in the striatum, 
cortex, and total hemisphere. More recently, Lebesgue et 
al.  [12] showed that intracerebroventricular administra-
tion of G-1 at the time of reperfusion improved the number 
of surviving CA1 pyramidal neurons in young and mid-
dle-aged OVX rats following global cerebral ischemia 
compared with vehicle treatment. Subsequently, both 
Zhang et al.  [11] and Lebesgue et al.  [12] suggested GPER 
to be an attractive candidate for therapeutic intervention 
against ischemic brain injury. However, nothing is yet 
known about the effect of stroke on GPER expression. We 
thus hypothesized that GPER expression in the brain is 
upregulated following 0.5-hour middle cerebral artery 
(MCA) occlusion. To address this hypothesis, we assessed 
GPER distribution and expression in the brains of male, 
female, and OVX mice at 24 h after stroke using immuno-
histochemical, Western blot, and PCR analysis.
 Methods 
 Animals 
 This study was conducted in accordance with National Health 
and Medical Research Council of Australia guidelines for the care 
and use of animals in research. A total of 84 mice were studied, 
consisting of 8- to 12-week-old males (n = 37; weight: 25.6  8 
0.4 g) and females (n = 47; weight: 21.2  8 0.2 g). Analyses of in-
farct volume and immunohistochemistry were performed on sec-
tions from the same groups of mice (male sham: n = 7; female 
sham: n = 6; OVX: n = 6; male stroke: n = 7; female stroke: n = 6; 
OVX stroke: n = 6). By contrast, analyses of protein expression by 
Western blotting were performed in brains from separate animals 
(male sham: n = 5; female sham: n = 5; OVX: n = 5; male stroke: 
n = 5; female stroke: n = 5; OVX stroke: n = 5). Moreover, PCR 
experiments were performed in separate animals (male sham:
n = 3; male stroke: n = 6). The mice had free access to water and 
standard rodent food pellets before and after surgery. Mice were 
excluded from the study if, during the surgical procedure to in-
duce cerebral ischemia, (a) the occluding clamp on the common 
carotid artery (CCA) was in place for  6 5 min (females: n = 2),
or (b) they died prior to 23.5 h reperfusion (males: n = 4; OVX:
n = 1).
 Ovariectomy of Female Mice 
 Ovariectomy was performed in anesthetized (80 mg/kg ket-
amine plus 10 mg/kg xylazine i.p.) 8- to 12-week-old female 
C57Bl/6J mice 7 days prior to cerebral ischemia, as previously de-
scribed  [13, 14] . Animals were culled 24 h after stroke and brains 
were removed for analysis. To confirm the effectiveness of OVX 
surgery, the uterus was harvested and weighed (intact females: 
123.5  8 22.0 mg; OVX: 76.1  8 51.0 mg).
 Focal Cerebral Ischemia 
 Mice were randomly assigned to study groups (e.g. sham or 
stroke) by an investigator not performing surgical procedures or 
data analysis. Moreover, the investigator performing the surgical 
procedure or data analysis (e.g. neurological assessment, infarct 
volume quantification, immunohistochemistry) was usually (and 
wherever possible) blinded to the treatment group to which the 
animal or tissue belonged. Focal cerebral ischemia was produced 
by transient occlusion of the MCA  [15–18] . Mice were anesthe-
tized with ketamine (80 mg/kg i.p.) plus xylazine (10 mg/kg i.p.) 
with rectal temperature monitored and maintained at 37.0  8 
0.5  °  C. The right carotid bifurcation was exposed through a ven-
tral midline neck incision and the external carotid artery (ECA) 
ligated distal to the bifurcation of the CCA and cut, forming an 
ECA stump. The CCA was clamped and tension applied to the 
internal carotid artery (ICA) using a suture bridge. A small nick 
was made in the ECA stump, and a 6-0 nylon monofilament with 
silicone-coated tip inserted and advanced distally along the ICA 
(11–12 mm distal to the carotid bifurcation), causing MCA occlu-
sion (MCAO) at its junction with the Circle of Willis. Severe 
(  75%) reduction in regional cerebral blood flow (rCBF) was con-
firmed using transcranial laser Doppler flowmetry (Perimed) in 
the area of cerebral cortex supplied by the MCA (  2 mm poste-
rior and   5 mm lateral to bregma). The filament was then tied in 
place, the CCA clamp removed and the suture bridge released. 
Occlusion was maintained for 30 min, and the filament retracted 
to allow reperfusion for 23.5 h (confirmed by an increase in rCBF). 
Sham-operated mice were anesthetized and the right carotid bi-
furcation exposed, but no filament was inserted.
 Functional Impairment 
 A hanging wire test was performed in which mice were sus-
pended by their forelimbs on a wire stretched between two posts 
30 cm above a foam pillow for up to 60 s  [15, 17, 19] . The time un-
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til the animal fell (a score of zero was assigned to animals that fell 
immediately and a score of 60 was assigned to animals that did 
not fall) was recorded and the average time of 3 trials with 5 min 
rest in between was calculated. This task is used as a measure of 
grasping ability and forelimb strength.
 Evaluation of Cerebral Infarct Volume 
 Mice were killed at 24 h after cerebral ischemia by isoflurane 
inhalation, followed by decapitation. The brains were immedi-
ately removed, snap frozen in liquid nitrogen, and stored at 
–80   °   C. Evenly spread (separated by   420   m) coronal sections 
(30   m thick) were obtained spanning the infarct, thaw mounted 
onto poly-L-lysine-coated glass slides, and stained with thionin 
(0.1%) to delineate the infarct. Images of the sections were cap-
tured with a CCD camera (Cohu Inc., San Diego, Calif., USA) 
mounted above a light box. Infarct volume was quantified using 
image analysis software (ImageJ, NIH), correcting for brain ede-
ma, according to the following formula: CIV = [LHA – (RHA – 
RIA)]  ! (thickness of section + distance between sections); where 
CIV is corrected infarct volume, LHA is left hemisphere area, 
RHA is right hemisphere area and RIA is right hemisphere infarct 
area. Edema volume was calculated using the formula: [RHA – 
LHA]  ! (thickness of section + distance between sections). Ede-
ma-corrected infarct volumes of individual brain sections were 
then added, giving a three dimensional approximation of the total 
infarct volume.
 GPER Immunohistochemistry 
 GPER immunoreactivity in the brain was performed using 
methods similar to those reported previously  [10] . Brains were 
removed and stored as described above. Multiple serial 10   m 
coronal sections that spanned the infarct (bregma +0.84, +0.42, 
0, –0.42, –0.84, –1.26, –1.68, and –2.10 mm) were taken for anal-
ysis. Brain sections were fixed in acetone and washed in 0.01  M 
phosphate-buffered saline (PBS, 3  ! 10 min). Ten percent goat 
serum was applied for 30 min and sections were then incubated 
in a GPR30 rabbit polyclonal antibody (1: 200; Abcam) overnight 
in a humid box. For a negative control, the primary antibody was 
pre-incubated with the blocking peptide for 1 h before being ap-
plied to the tissue sections. The following day, tissues were 
washed in 0.01  M PBS (3  ! 10 min) to remove excess antibody, 
and incubated in a Texas Red-conjugated goat anti-rabbit IgG
(1: 200; Zymed Laboratories) for 2–3 h in a humid box. Sections 
were then washed in PBS (3  ! 5 min), mounted and cover-
slipped.
 Human brain tissue (see human case reports below) was ob-
tained and fixed in 10% neutralized formalin for a minimum of 2 
weeks before being processed in paraffin wax, cut into slices and 
stored at 4   °   C. GPER immunohistochemistry was performed on 
these sections using a similar process as described above. In ad-
dition, tissue sections were blocked with a peroxidase blocking 
agent for 10 min and then washed in PBS (3  ! 10 min) prior to 
adding 10% goat serum. Furthermore, the primary antibody was 
recognized using the DAKO EnVision + system (DAKO). Sections 
were incubated for 45 min with a peroxidase-labeled polymer 
conjugated to goat anti-rabbit IgG, washed in PBS (3  ! 10 min), 
followed by incubation with diaminobenzidine for 5 min.
 To identify in which cell type GPER was located, double-la-
beled immunofluorescence was performed on brain sections 
from sham and stroke mice. Unfortunately, we were unable to 
carry out these studies on human brain samples as we had limited 
access to this tissue. Brain sections were prepared as described 
above and simultaneously incubated with a GPR30 rabbit poly-
clonal antibody (1: 200; Abcam) and either a NeuN mouse mono-
clonal antibody (1: 1,000; Chemicon) or a von Willebrand factor 
(vWF) mouse monoclonal antibody (1: 1,000; Abcam) overnight 
in a humid box. The following day, tissues were washed in 0.01 M 
PBS (3  ! 10 min) and incubated in a Texas Red-conjugated goat 
anti-rabbit IgG (1: 200; Zymed Laboratories) for 2–3 h in a humid 
box. Sections were then again washed in 0.01 M PBS (3  ! 5 min) 
and incubated in a biotinylated anti-mouse IgG reagent for 10 
min. Brain sections were then washed in 0.01 M PBS (3  ! 10 min) 
and Fluorescein Avidin DCS (Vector Laboratories) was applied 
for 5 min. Sections were washed in 0.01 M PBS (3  ! 10 min) and 
coverslipped. All tissue-mounted slides used for immunohisto-
chemistry were viewed and photographed with an Olympus fluo-
rescence/light microscope.
 GPER immunoreactivity was examined in 5 structures
of mouse brain: the hippocampus at 3 levels from bregma –1.26
to –2.1 mm, the somatosensory cortex at 8 levels from +0.84 to 
–2.1 mm, the striatum at 5 levels from +0.84 to –0.84 mm, the 
thalamus at 3 levels from –1.26 to –2.10, and the hypothalamus at 
4 levels from bregma –0.84 to –2.1 mm. These structures were 
chosen because the infarct core (striatum and thalamus) and peri-
infarct zone (hippocampus, somatosensory cortex, and hypothal-
amus) are typically observed in these regions of the brain of the 
MCAO mouse model. GPER immunoreactivity in the mouse 
brain was observed at a magnification of  ! 200 or  ! 400 and each 
region was given a score based on the subjective judgment of two 
blinded observers. Human brain sections were examined at a 
magnification of  ! 4,  ! 100,  ! 200, and  ! 400. All the appropriate 
primary and secondary controls were performed.
 Western Blot Analysis 
 Expression of GPER was measured in homogenates of the en-
tire right (ischemic) cerebral hemisphere from mice following 
sham or stroke surgery using Western blotting. The right hemi-
spheres were removed, snap frozen in liquid nitrogen and ho-
mogenized in Laemmli buffer. Protein concentration was deter-
mined using the reducing agent and detergent compatible (RC 
DC) protein assay. Equal amounts of protein were loaded onto a 
10% polyacrylamide gel and transferred to a polyvinylidene 
membrane. Membranes were blocked with 5% skim milk in TBS-
T (Tris-buffered saline in 0.1% Tween 20) for 1 h and then incu-
bated overnight (4   °   C) with the appropriate primary antibody 
(GPER or   -actin) in 5% skim milk and TBS-T. Membranes were 
then incubated for 1 h with a horseradish peroxidase-conjugated 
anti-rabbit IgG for GPER and HRP-conjugated anti-mouse IgG 
for   -actin. Immunoreactive bands were detected by enhanced 
chemiluminescence, quantified using a ChemiDoc XRS molecu-
lar imager and normalized to the intensity of corresponding 
bands for   -actin.
 Quantitative Real-Time PCR 
 Total RNA was isolated from the entire right hemisphere from 
male mice using the RNeasy Mini Kit with oncolumn DNase step 
(Qiagen, Hilden, Germany) followed by cDNA conversion using 
the Quantitect Reverse transcription kit (for Taqman  gene ex-
pression assays; Qiagen). We did not examine the right cerebral 
hemisphere from intact female or OVX mice because the immu-
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nohistochemical and Western blot data indicated that stroke had 
little or no effect on GPER expression in the female brain, which 
was in contrast to males. Pre-designed Taqman gene expression 
assays were then used to specifically measure mRNA expression 
of GPER (Mn01194815; NCBI Reference Sequence: RefSeq 
NM_029771.3), ER  (Mn01191130; RefSeq NM_007956.4) and 
ER  (Mn00599820; RefSeq NM_NM010157.3), and   -actin 
(Mn4352341; RefSeq NM_007393.1; Applied Biosystems, Carls-
bad, Calif., USA) as a house-keeping gene. Assays were performed 
according to the manufacturer’s instructions using the Bio-Rad 
CFX96TM real-time PCR machine (Bio-Rad, Hercules, Calif., 
USA). Data were normalized to the housekeeping gene and calcu-
lated as changes in fold expression relative to sham using the for-
mula: fold change = 2 –   CT .
 Human Case Reports 
 Brain tissue was obtained from stroke patients at National Tai-
wan University Hospital and the study was approved by the Na-
tional Taiwan University Hospital ethics committee.
 Patient 1. This 40-year-old man was diagnosed with pancyto-
penia, with a bone marrow biopsy suggesting severe aplastic ane-
mia. There was a poor response to treatment, which included 
bone marrow transplantation, and the patient died due to repeat-
ed severe infections and associated cardiac and respiratory fail-
ure. 
 Patient 2 . This 1-year-old girl had decreased oral intake, 
weight loss, and was pale for several months. Distended abdomen 
with severe hepatosplenomegaly was noted and cytomegalovirus 
infection was suspected after liver and spleen biopsies. Ganciclo-
vir and Cytotec were given but the patient died due to progressive 
hepatosplenomegaly and associated multiple medical complica-
tions. 
 Patient 3 . A 39-year-old man had an acute brainstem stroke 
and died after 9 days with massive infarcts and obstructive hydro-
cephalus. Acute basilar artery occlusion related to atherosclerosis 
and associated thrombi were suggested as possible causes of death 
on autopsy. 
 Patient 4 . This 45-year-old female had sudden loss of con-
sciousness and CT revealed acute subarachnoid hemorrhage and 
intracerebral hemorrhage in the left frontal area. Angiography 
showed an anterior communicating artery aneurysm and opera-
tion was performed. Follow-up CT 10 days later showed acute in-
farct in the left anterior cerebral artery territory. The patient then 
suffered from severe sepsis and gastroenteric paralysis, leading to 
multiple organ failure and disseminated intravascular coagula-
tion and the patient died 22 days after stroke onset.
 Statistical Analysis 
 All data are presented as mean  8 standard error. Statistical 
analyses were performed using GraphPad Prism version 5 (Graph-
Pad Software Inc., San Diego, Calif., USA). Between-group com-
parisons were compared using one-way ANOVA, a Student’s un-
paired t test or a one sample t test, as appropriate. If differences 
were detected by ANOVA, individual groups were compared with 
the Student-Newman-Keuls test. Statistical significance was ac-
cepted when p  ! 0.05.
 Results 
 rCBF decreased to   20–30% of the pre-ischemia level 
for the duration of MCAO in males, intact females, and 
OVX mice ( fig.  1 a). rCBF returned to   100% within
5 min of the withdrawal of the monofilament, and then 
stabilized between 80 and 90% after 30 min of reperfu-
sion. Mortality rate following ischemia reperfusion was 
similar between males, intact females, and OVX females 
(5–10%; data not shown). Hanging wire times were sig-
nificantly reduced in males and OVX mice versus intact 
females ( fig. 1 b). Consistent with hanging wire outcomes, 
cerebral infarct volume was significantly larger in males 
versus intact females and appeared increased, but was not 
significantly different in OVX versus intact female mice 
( fig. 1 c, d). There was no significant difference in edema 
values between groups (data not shown).
 Localization of GPER in the Brain after Stroke 
 A specific anti-GPER antibody was used to identify 
the distribution of GPER in the mouse brain after sham 
or stroke surgery. The GPER immunoreactivity data pre-
sented are semi-quantitative assessments based on sub-
jective judgment of two independent observers. Moder-
ate GPER immunoreactivity was observed in most areas 
of the brain examined in sham animals of both sexes 
( fig.  2 ,  table  1 ). However, high immunoreactivity was 
present in the striatum and thalamus of males and fe-
males, whereas low GPER immunoreactivity was ob-
served in the hypothalamus of OVX mice. The pattern of 
GPER immunoreactivity indicated that GPER was local-
ized in neurons and cerebral capillaries. This was con-
firmed using double-labeling immunohistochemistry, 
which revealed GPER immunofluorescence co-localized 
with the neuronal marker, NeuN, and the endothelial cell 
marker, vWF ( fig. 3 ). Importantly, very weak or no im-
munoreactivity was present in sections incubated with 
the GPER antibody pre-absorbed with the GPER block-
ing peptide, consistent with specific immunostaining 
( fig. 3 h).
 In male mice 24 h after stroke, GPER immunoreactiv-
ity was increased in all 3 peri-infarct regions: hippocam-
pus, somatosensory cortex, and hypothalamus ( fig. 2 ,  ta-
ble 1 ). In contrast, GPER immunoreactivity was decreased 
in the striatum and thalamus following stroke ( fig. 2 ,  ta-
ble  1 ). Furthermore, GPER immunoreactive neurons in 
the peri-infarct regions of the male brain after stroke ap-
peared to be more intensely labeled in comparison to 
sham controls. In brains of intact females assessed 24 h 
after stroke, GPER immunoreactivity was decreased in 
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 Fig. 1. rCBF, infarct volume and hanging wire scores at 24 h in male, female, and OVX mice.  a rCBF was re-
corded during and after 30-min MCAO with reperfusion. Hanging wire scores ( b ), representative thionin-
stained coronal brain sections ( c ), and cerebral infarct volumes ( d ) are shown from male, intact female, and 
OVX mice after MCAO. Data are presented as mean  8 SEM.  *  p  ! 0.05 vs. male;  #  p  ! 0.05 vs. intact female. 
Table 1. S emi-quantitative analysis of the distribution of GPER immunoreactivity in the brain of male (n = 7), 
female (n = 6), and OVX (n = 6) mice 24 h after sham or stroke surgery
Brain region Male Female O VX
sham stroke sham stroke sh am stroke
Peri-infarct Hippocampus
CA1 ++ +++ + + + +
CA2 + ++ ++ + ++ +
CA3 ++ +++ ++ + ++ ++
Somatosensory cortex ++ +++ ++ ++ ++ ++
Hypothalamus ++ +++ ++ ++ + +
Infarct Striatum +++ ++ +++ ++ ++ +
Thalamus +++ ++ +++ ++ ++ +
Int ensity of label: + = low; ++ = moderate; +++ = high.
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the hippocampus, striatum, and thalamus, but not in the 
hypothalamus ( fig. 2 ,  table 1 ). In addition, less GPER im-
munoreactivity was observed in the striatum, thalamus, 
and the CA2 region of the hippocampus in OVX mice af-
ter stroke, but GPER distribution was unchanged in the 
somatosensory cortex and hypothalamus ( fig. 2 ,  table 1 ).
 GPER immunoreactivity was also assessed post mor-
tem in 2 male and 2 female human brains – one non-stroke 
and one stroke patient per sex – and these studies provid-
ed the first anatomical evidence that GPER is expressed in 
the human brain ( fig. 4 ). These data are obviously prelim-
inary, qualitative and uncontrolled, and our observations 
Striatum (infarct core)
Male Intact female OVX
Sham
Stroke
Somatosensory cortex (peri-infarct zone)
Male Intact female OVX
Stroke
Sham
 Fig. 2. Representative photomicrographs showing GPER immunoreactivity in the infarct (striatum) and peri-
infarct (somatosensory cortex) regions of the brain from male (n = 7), female (n = 6), and OVX (n = 6) mice
24 h after sham or stroke surgery. Scale bar = 100   m. 
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require careful follow-up via group data. Nevertheless, 
consistent with the immunohistochemical findings in 
mice, GPER immunostaining in the ischemic hemisphere 
appeared to be higher in the post-stroke male brain com-
pared with the control male, whereas little difference in 
immunoreactivity was noted between the female patients 
( fig. 4 ). In contrast to mice, however, no GPER immuno-
reactivity was observed in the cerebrovasculature.
 Protein Expression and mRNA Levels of GPER in the 
Brain after Stroke 
 We examined protein expression of GPER in the mouse 
brain following stroke, as well as mRNA levels of GPER 
and the traditional estrogen receptors, ER  and ER  . 
Supporting the immunohistochemical observations, we 
found that GPER protein expression as measured by West-
ern blotting was increased in male brains 24 h after stroke 
( fig. 5 a, b). Conversely, GPER expression was not different 
between brains from intact female and OVX mice 24 h 
after stroke or sham stroke surgery ( fig. 5 a, c, d). These 
findings are consistent with our separate immunohisto-
chemical analyses of most brain regions examined in in-
tact female and OVX mice following stroke. Furthermore, 
mRNA expression of GPER in the ischemic hemisphere of 
male mouse brains was elevated at 4 h after stroke (p  ! 
0.05), but had returned to the baseline level by 24 h ( fig. 6 a). 
Unlike GPER, however, ER  and ER  mRNA expression 
at 4 h after stroke was not significantly altered ( fig. 6 b, c).
ba
f
c
ed
ihg
 Fig. 3. GPER is located in neurons and the cerebral microvasculature. Representative photomicrographs showing 
GPER ( a ,  d ,  g ), NeuN ( b ) or vWF ( e ) in the brain from male mice. Overlayed images revealing GPER is co-local-
ized with NeuN ( c ) and vWF ( f ). Control sections showing very faint or no GPER immunoreactivity following 
the addition of the GPER blocking peptide ( h ) or the removal of the GPER antibody ( i ). Scale bar = 50   m. 
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 Discussion 
 This is the first study to assess GPER distribution and 
expression in the brain after stroke. The findings indicate 
that in the male brain GPER distribution and expression 
is increased following stroke, whereas little or no change 
occurs in intact or OVX females. In addition, preliminary 
data indicate that GPER is expressed in the human brain 
and its distribution may be greater in the male but not 
female after stroke. Our studies in mice further demon-
strated that GPER is localized in both neurons and the 
cerebral microvasculature. Overall, the findings from 
this study suggest that stroke differentially affects GPER 
expression and distribution in the brain of males and fe-
males (whether intact or OVX), and could thus play a sex-
specific role in stroke outcome.
 In recent years, it has become apparent that GPER 
plays a prominent role in multiple aspects of the central 
nervous system  [20] . Except for a few select regions in the 
brain  [21] , GPER distribution is generally distinct from 
that of classical estrogen receptors, and in fact, appears to 
be more highly expressed  [6] . Previous studies by Brailoiu 
et al.  [9] and Hazell et al.  [6] demonstrated that GPER 
50 μm
Stroke
Patient 4Patient 3
Non-
stroke
Patient 1 Patient 2
 Fig. 4. Photomicrographs showing GPER 
immunoreactivity (arrows) in human 
brain sections from non-stroke (patient 1, 
male; patient 2, female) or stroke (patient 
3, male; patient 4, female) individuals. 
Magnification  ! 200 (inset  ! 400). 
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 Fig. 5.  a Representative Western blot showing GPER protein ex-
pression in the ischemic cerebral hemisphere of male, female, and 
OVX mice.  b–d Immunoblot analysis of GPER band intensities 
revealed that stroke increased GPER levels in male brains (n = 5) 
but had little or no effect in female (n = 5) and OVX (n = 5) brains. 
Data are presented as mean  8 SEM.  *  p  ! 0.05 vs. sham. 
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distribution is moderate to high within many areas of the 
brain, including the hippocampus, somatosensory cor-
tex, thalamus, striatum, and hypothalamus. In addition, 
both studies reported that GPER distribution in the rat 
 [6, 9] and mouse  [6] brain is comparable between sexes. 
Consistent with this, the current findings demonstrate a 
moderate level of GPER immunoreactivity in the hippo-
campus, somatosensory cortex, and hypothalamus of 
male and female control mice. Moreover, a high level of 
GPER immunoreactivity was observed in the striatum 
and thalamus in both sexes. These findings are, however, 
in contrast to those of Canonaco et al.  [22] who reported 
that a sexually dimorphic GPER expression pattern oc-
curs in the hypothalamus and thalamus of the hamster. 
Nevertheless, there is accumulating evidence that GPER 
distribution in the brain is typically quite similar be-
tween males and females. A moderate level of GPER im-
munoreactivity was also observed in the hippocampus 
and somatosensory cortex of OVX mice following sham 
surgery. Unlike males and intact females, however, only 
a moderate level of GPER immunoreactivity was detected 
in the striatum and a low level of GPER was distributed 
in the hypothalamus. This latter finding is consistent 
with recent observations by Spary et al.  [8] who showed 
that the number of GPER-positive cells in the paraven-
tricular nucleus, a discrete band of nerve cells in the an-
terior part of the hypothalamus, is decreased in females 
following OVX. Thus, it seems that estrogen may have a 
greater effect on GPER expression in some brain regions 
compared to others.
 Immunohistochemical studies have identified that 
GPER is not predominantly expressed in any one neuro-
nal phenotype. For example, GPER is co-localized with 
nitrergic neurons, TH-positive catecholaminergic neu-
rons, ChAT-positive cholinergic neurons, 5-HT-positive 
serotonergic neurons, and oxytocin and vasopressin neu-
rons  [8] . In the current study, the pattern of GPER-posi-
tive immunoreactivity appeared to be located in neurons 
and the microvasculature. To confirm that GPER was ex-
pressed in neurons, we performed double-labeled immu-
nohistochemistry using the GPER antibody and the neu-
ronal cell marker, NeuN. GPER immunoreactivity was 
co-localized with NeuN, thus verifying that GPER is lo-
cated in the neuronal soma (cell body). GPER immuno-
reactivity appeared to be located in the neuronal cyto-
plasm, most likely in the endoplasmic reticulum and/or 
Golgi apparatus, as widely reported  [1, 8, 9, 23, 24] . In ad-
dition, the current study showed for the first time that 
GPER immunoreactivity is also co-localized with the en-
dothelial cell marker, vWF. This indicates that GPER is 
expressed in the endothelium of the cerebral microvascu-
lature. This observation in small parenchymal vessels is 
consistent with our finding that GPER is present in both 
the endothelium and vascular smooth muscle of the rat 
CCA and MCA  [10] . It is worth noting that in some small 
cerebral arterioles, the orientation of GPER immunore-
activity suggested that it was also located in the smooth 
muscle. It is tempting to speculate that since GPER medi-
ates cerebral vasodilatation, as reported by our group  [10] 
and by others  [25] , perhaps GPER signaling in cerebral 
vessels improves blood flow to the infarct and penumbra 
region, thereby providing neuroprotection following 
stroke.
 Due to its high expression and widespread distribu-
tion in the brain and cerebral vasculature, GPER is a po-
tential therapeutic target for stroke. In fact, preliminary 
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 Fig. 6. Time-dependent expression of es-
trogen receptors in the mouse brain after 
cerebral ischemia reperfusion. Data from 
Taqman assays showing expression of 
mRNA for GPER ( a ), ER  ( b ), and ER  ( c ) 
in ischemic hemisphere after 0.5 h isch-
emia plus 4 or 24 h reperfusion relative to 
sham (n = 3 per group). Data are presented 
as mean  8 SEM.  *  p  ! 0.05 vs. sham. 
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studies by Zhang et al.  [11] and Lebesgue et al.  [12] dem-
onstrated that the GPER agonist, G-1, reduces stroke-in-
duced brain damage in OVX rodents. However, it re-
mained to be determined as to whether GPER distribu-
tion and expression in the brain is increased following 
stroke. The present study found that GPER distribution 
in the brain is increased in male mice after stroke. More 
specifically, GPER distribution in the hippocampus, so-
matosensory cortex, and hypothalamus is increased in 
mice subjected to stroke. It is these brain regions that typ-
ically correspond with the peri-infarct zone of the mouse 
model of stroke. In contrast, stroke did not alter GPER 
distribution in the striatum, and it was decreased in the 
thalamus. A likely explanation for the lack of change in 
GPER distribution in the striatum and thalamus is that 
neuronal loss is greatest in these two areas following 
stroke. Consistent with these findings in the peri-infarct 
regions of the brain, Western blot analysis revealed that 
GPER protein expression is selectively increased in the 
ipsilateral hemisphere of male mice. Furthermore, GPER 
mRNA levels were also found to be elevated in the male 
brain at 4 h after stroke. Interestingly however, ER  
mRNA levels in the male brain were not altered after 
stroke. This finding correlates with observations by 
Westberry et al.  [26] , who reported that ER  mRNA lev-
els do not change in the ischemic cortex of male rats.
 It is becoming increasingly recognized that stroke is a 
sexually dimorphic disease. For example, ER  mRNA 
expression in the ischemic cortex of male rodents is not 
altered following stroke  [26, 27] . In contrast, several stud-
ies have reported that ER  mRNA expression is increased 
in the ischemic cortex of vehicle- and estradiol-treated 
OVX female rodents  [26–28] , which indicates that ER  
levels are elevated following stroke in females indepen-
dent of the level of circulating estrogen. Conversely, the 
current study found that GPER immunoreactivity in the 
female brain did not change following stroke, except in 
the hippocampus, in which distribution was decreased. 
Similarly, GPER distribution in the OVX brain was either 
not altered (somatosensory cortex, hypothalamus) or re-
duced (hippocampus, striatum, and thalamus) following 
ischemia. In the male brain, however, GPER distribution 
was increased in the hippocampus, somatosensory cor-
tex, and the hypothalamus. These findings were support-
ed by Western blot analysis showing that GPER protein 
expression in the ischemic hemisphere is only elevated in 
males. Together these findings suggest that GPER distri-
bution and expression in the male, but not the intact fe-
male or OVX brain, is increased following stroke. Col-
lectively, increased GPER and ER  expression in the isch-
emic hemisphere of males and females, respectively, 
suggests that these estrogen receptors could play sex-spe-
cific roles following stroke.
 In the human brain, GPER has been reported to be 
highly expressed in the primary olfactory cortex, olfac-
tory tubercle, nucleus of the lateral olfactory tract, hip-
pocampal areas of Ammon’s horn and dentate gyrus  [29] .
Furthermore, GPER mRNA was found to be densely dis-
tributed in the hypothalamic nuclei, such as the paraven-
tricular, supraoptic, arcuate, and suprachiasmatic nuclei 
 [29] . However, the current study is the first to examine 
GPER localization in the human brain after stroke. Our 
preliminary data suggest that GPER distribution may be 
increased in the male human brain following stroke.
 In summary, the present study provides evidence that 
GPER distribution is increased in mouse brain regions 
corresponding with the peri-infarct zone of our MCAO 
model of stroke, in males but not intact female or OVX 
brains. These findings shed further light on the highly 
complex estrogen signaling cascade in male and female 
brains following stroke. Overall, GPER is potentially an 
important therapeutic target following stroke, especially 
in males, in whom estrogen therapy is not feasible.
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